腦脊液管理市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

腦脊液管理市場主要受到全球腦積水患病率上升和人口老齡化的推動。

根據國家腦積水基金會 2018 年關於腦積水的事實，腦積水是最常見的出生缺陷之一，每年每 500 名兒童中就有 1 名受到影響，每年還會增加 6,000 名兒童。出生兩年後，他患上了腦積水. 此外，老年人腦積水的發病率也很高。 全球神經系統疾病負擔的增加預計將推動市場增長。 此外，不斷增加的研發和產品發布以及設備技術的進步正在推動市場的增長。 然而，意識低下、缺乏熟練的專業人員以及 FDA 最近的警告預計會阻礙市場增長。

腦脊液管理市場的趨勢

分流器市場有望顯著擴大

分流系統將多餘的腦脊液從大腦排出到身體的其他部位，並在循環過程中被吸收。 腦脊液分流器包含三個主要組件：流入管（導管）、調節流體流動的閥門和將流體輸送到腹部和心臟並在那裡被吸收的流出導管。它由 3 個組件組成。

分流器相對於傳統引流技術的優勢，加上腦脊髓分流器技術的進步，預計將在預測期內推動細分市場的增長。 2017 年 11 月，Alcyone Lifesciences 獲得美國食品和藥物管理局批准用於治療腦積水的 Alivio Ventricular Catheter & Flusher System（Alivio System）。

此外，由於人口老齡化帶來的神經系統疾病負擔增加，因此按患者類型劃分，老年醫學領域有望實現顯著的市場增長。

北美有望實現顯著增長

由於發達的醫療基礎設施、對腦積水治療方法的認識不斷提高以及大公司的存在，預計北美將實現顯著增長。 據腦積水協會估計，大約有 100 萬美國人在其生命的各個階段都患有腦積水。 據估計，美國每 770 個嬰兒中就有 1 個會患上腦積水。 此外，由於對神經系統疾病和治療的認識不斷提高，以及腦積水的負擔不斷增加，預計亞太地區將經歷利潤豐厚的市場增長。

腦脊液管理市場競爭分析

全球腦脊液管理市場競爭適中。 市場參與者正專注於新產品發布、產品創新和地域擴張，以鞏固其市場份額。 例如，Arkis BioSciences Inc. 的 Cerebroflo 腦室外引流 (EVD) 導管已獲得 FDA 批准，這是第一個包含永久性聚合物添加劑 Endexo 的神經導管。 市場上的主要參與者包括 Medtronic Plc、B. Braun Melsungen AG、Integra Lifesciences (Arkis BioSciences)。

其他福利。

• Excel 格式的市場預測 (ME) 表
• 三個月的分析師支持

內容

第一章介紹

• 調查結果
• 調查假設
• 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

• 市場概覽
• 市場驅動因素
  • 腦積水和其他神經系統疾病的負擔增加
  • 微創手術的流行和老年人口的增加
• 市場製約因素
  • 缺乏熟練的專業人員
  • 與腦脊液管理系統相關的並發症
• 波特的五力分析
  • 新進入者的威脅
  • 買方/消費者議價能力
  • 供應商的議價能力
  • 替代品的威脅
  • 競爭公司之間的敵對關係

第 5 章市場細分

• 按產品分類
  • 調車
    • 通過閥門
    • 可調節分流閥
    • 單壓力閥分流器
    • 按類型
    • 小靜脈腹膜 (VP) 分流術
    • 心房 (VA) 分流術
    • 腰腹腔 (LP) 分流術
    • 靜脈胸膜 (VPL) 分流
  • 體外血管引流裝置
• 按地區細分
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 中東和非洲
    • 海灣合作委員會
    • 南非
    • 其他中東和非洲地區
  • 南美洲地區
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章競爭格局

• 公司簡介
  • Medtronic Plc
  • B. Braun Melsungen AG
  • Integra Lifesciences（Arkis BioSciences）
  • Natus Medical Incorporated
  • Sophysa
  • Johnson & Johnson
  • Spiegelberg GmbH & Co. KG
  • Moeller Medica

第7章 市場機會今後動向

The cerebrospinal fluid management market is primarily driven by the growing hydrocephalus worldwide and the growing geriatric population. According to National Hydrocephalus Foundation, facts about hydrocephalus 2018, hydrocephalus is one of the most common birth defects and each year, one out of the 500 children suffers from hydrocephalus, and another 6000 children annually develop hydrocephalus during the first two years of the life. Moreover, the rate of hydrocephalus is also high in the older population. The growing burden of neurological disorders around the world is anticipated to boost the market growth. Moreover, the increasing R&D in advancements of device technologies coupled with the product launches are fueling the market growth. However, lack of awareness, the dearth of skilled professionals and recent warning letters from the FDA are anticipated to hinder the market growth.

Cerebrospinal Fluid Management Market Trends

Shunts are Expected to Have Significant Market Growth

These shunt systems remove excess cerebrospinal fluid from the brain to other parts of the body where the fluid is absorbed as part of the circulatory process. Cerebrospinal fluid shunts contain three main components i.e. an in-flow tube (catheter), a valve that regulates the flow of fluid, and an outflow catheter that carries the fluid to the abdomen or the heart where the fluid can be absorbed.

The advantages of shunts over the traditional drainage procedures coupled with the advancements in cerebrospinal shunt technologies are anticipated to boost the segment growth over the forecast period. In November 2017, Alcyone Lifesciences has received U.S. Food and Drug Administration approval for Alivio Ventricular Catheter & Flusher System (Alivio System) for the treatment of hydrocephalus.

Moreover, among the patient types, the geriatric segment anticipated having the notable market growth owing to the increasing burden of neurological disorders with an aging population.

North America is Anticipated to Have Significant Growth

Among the regions, North America is anticipated to grow at significant rates owing to the well-established healthcare infrastructure, growing awareness regarding the available options for treatment of hydrocephalus and the presence of key market players in the region. Hydrocephalus Association has estimated that around 1 million Americans are affected by hydrocephalus in every stage of life. Also, one out of the 770 babies in America, develops hydrocephalus. Moreover, Asia Pacific is anticipated to have the lucrative market growth owing to the growing awareness regarding the neurological disease and treatment options coupled with the growing burden of hydrocephalus in the region.

Cerebrospinal Fluid Management Market Competitive Analysis

The global cerebrospinal fluid management market is moderately competitive. Market players are focusing on new product launches, product innovations and geographical expansion to strengthen its market share. For instance, Arkis BioSciences Inc. has received FDA approval for its External Ventricular Drainage (EVD) Catheter, CerebroFlo, the first neuro catheter to incorporate Endexo, a permanent polymer additive. The key market players operating in the market include Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences (Arkis BioSciences),

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Burden of Hydrocephalus and Other Neurological Disorders
  • 4.2.2 Growing Adoption of Minimally Invasive Solutions and Rising Geriatric Population
• 4.3 Market Restraints
  • 4.3.1 Dearth of Skilled Professionals
  • 4.3.2 Complications Related to Cerebrospinal Fluid Management Systems
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Products
  • 5.1.1 Shunts
    • 5.1.1.1 By Valve
    • 5.1.1.1.1 Adjustable Valve Shunts
    • 5.1.1.1.2 Monopressure Valve Shunts
    • 5.1.1.2 By Type
    • 5.1.1.2.1 Ventriculoperitoneal (VP) Shunts
    • 5.1.1.2.2 Ventriculoatrial (VA) Shunts
    • 5.1.1.2.3 Lumboperitoneal (LP) Shunts
    • 5.1.1.2.4 Ventriculopleural (VPL) Shunts
  • 5.1.2 ExternaL Vascular Drainage Devices
• 5.2 By Geography
  • 5.2.1 North America
    • 5.2.1.1 United States
    • 5.2.1.2 Canada
    • 5.2.1.3 Mexico
  • 5.2.2 Europe
    • 5.2.2.1 Germany
    • 5.2.2.2 United Kingdom
    • 5.2.2.3 France
    • 5.2.2.4 Italy
    • 5.2.2.5 Spain
    • 5.2.2.6 Rest of Europe
  • 5.2.3 Asia-Pacific
    • 5.2.3.1 China
    • 5.2.3.2 Japan
    • 5.2.3.3 India
    • 5.2.3.4 Australia
    • 5.2.3.5 South Korea
    • 5.2.3.6 Rest of Asia-Pacific
  • 5.2.4 Middle-East and Africa
    • 5.2.4.1 GCC
    • 5.2.4.2 South Africa
    • 5.2.4.3 Rest of Middle-East and Africa
  • 5.2.5 South America
    • 5.2.5.1 Brazil
    • 5.2.5.2 Argentina
    • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Medtronic Plc
  • 6.1.2 B. Braun Melsungen AG
  • 6.1.3 Integra Lifesciences (Arkis BioSciences)
  • 6.1.4 Natus Medical Incorporated
  • 6.1.5 Sophysa
  • 6.1.6 Johnson & Johnson
  • 6.1.7 Spiegelberg GmbH & Co. KG
  • 6.1.8 Moeller Medica

7 MARKET OPPORTUNITIES AND FUTURE TRENDS